IAS-USA releases updated HIV treatment and prevention guidelines
On the occasion of World AIDS Day on 1 December 2024, the International Antiviral (formerly AIDS) Society-USA (IAS-USA) has published new international ...
Tag: Prophylaxis
Study links fungal heteroresistance to fatal bloodstream infections in bone marrow transplant patients
Emory researcher David Weiss has spent years studying a baffling phenomenon called heteroresistance, in which a tiny fraction of bacteria ...
Breakthrough in hemophilia A treatment: Sobi's ALTUVOCT receives EU marketing authorization
Sobi® today announced the European Commission has granted Marketing Authorization for ALTUVOCT™ (efanesoctocog alfa), for the treatment and prevention of bleeds ...
New stem cell transplant approach may expand donor pool for high-risk blood cancer patients
A new treatment approach using an older drug may enable more patients with high-risk blood cancers to receive transplanted stem ...
Novel bispecific antibodies show promise against evolving SARS-CoV-2 variants
In a recent research paper uploaded to the bioRxiv preprint* server, researchers developed and tested novel bispecific antibodies (bsAbs) comprising ...
Drug repurposing study finds lonafarnib effective against RSV
In a study published in the journal Nature Communications, researchers screened ReFRAME (short for repurposing, focused rescue, and accelerated Medchem), ...
PrEP, a key HIV prevention tool, isn’t reaching Black women
Alexis Perkins thought her OB-GYN's office in Atlanta would be just the place to get a prescription for the type ...
New formulation can provide up to six months of full protection against HIV
For people at high risk of contracting HIV, missing doses of their daily HIV prevention pills can have big consequences. ...
What is the association between farnesoid X receptor inhibition and protection against COVID-19?
In a recent study published in Nature, researchers assessed the association between farnesoid X receptor (FXR) inhibition and severe acute ...
Mucosal IgA fused nanobody as a non-invasive, cost-effective prophylaxis and therapeutic option against major SARS-CoV-2 variants
In a recent study published in Frontiers in Immunology, a team of researchers from the United States developed an affordable, non-invasive, ...
